Estimate Recalculated Nov 5, 2024 07:08PM EST
Lori Anne Kunkel has an estimated net worth of $9.72 Million. This is based on reported shares across multiple companies, which include Nurix Therapeutics, Inc., Loxo Oncology, Inc., CURIS INC, Tocagen Inc, Oric Pharmaceuticals, Inc., PHARMACYCLICS INC, and Enliven Therapeutics, Inc..
Lori Anne Kunkel's CIK is 0001536368
2018 was Lori Anne Kunkel's most active year for acquiring shares with 7 total transactions. Lori Anne Kunkel's most active month to acquire stocks was the month of May. 2018 was Lori Anne Kunkel's most active year for disposing of shares, totalling 15 transactions. Lori Anne Kunkel's most active month to dispose stocks was the month of May. 2018 saw Lori Anne Kunkel paying a total of $229,948.16 for 251,142 shares, this is the most they've acquired in one year. In 2019 Lori Anne Kunkel cashed out on 119,392 shares for a total of $24,594,701.44, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!